| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Mobile-health Network Solutions: Mobile-health Network Solutions Announces Effective Date of Reverse Stock Split | 241 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 25, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a... ► Artikel lesen | |
| 24.06. | Mobile-health Network Solutions: Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OtterSG Bundled Solution for Clinics in Singapore | 505 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MHNS"), a leading AI-powered digital health platform headquartered in Singapore, today announced... ► Artikel lesen | |
| 23.06. | Mobile-health Network Solutions: Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OttterSG Bundled Solution for Clinics in Singapore | 461 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 23, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MHNS"), a leading AI-powered digital health platform headquartered in Singapore, today announced... ► Artikel lesen | |
| 18.06. | Mobile-health Network Solutions: Mobile-health Network Solutions Announces Change in Effective Date of Reverse Stock Split | 297 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 18, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a... ► Artikel lesen | |
| 18.06. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.06. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 13.05. | Mobile-health Network Solutions: Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion | 357 | Newsfile | Singapore, Singapore--(Newsfile Corp. - May 13, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced that... ► Artikel lesen | |
| 13.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 04.05. | Mobile-health Network Solutions signs MOU for $119m investment | 4 | Investing.com | ||
| 04.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.04. | Mobile-health Network Solutions secures $126M investment | 3 | Investing.com | ||
| 28.04. | Mobile-health Network Solutions: Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center Campus | 539 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 28, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced... ► Artikel lesen | |
| 24.04. | MNDR secures 60MW AI data center capacity in Malaysia | 1 | Investing.com | ||
| 24.04. | MNDR erweitert Kapazität für KI-Rechenzentren in Malaysia auf 60 MW | 1 | Investing.com Deutsch | ||
| 24.04. | Mobile-health Network Solutions: Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW | 483 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company") today announced that it has secured an additional 35 megawatts... ► Artikel lesen | |
| 24.04. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 17.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 13.04. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,472 | -1,26 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,660 | +6,69 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,560 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 39,400 | 0,00 % | Inspire Medical Systems, Inc. - 8-K, Current Report | ||
| INSPIREMD | 0,635 | +5,83 % | InspireMD Inc.: InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures | MIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,487 | 0,00 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,950 | -2,46 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 0,893 | -8,50 % | MYOMO, INC. - 8-K, Current Report | ||
| INTELLIGENT BIO SOLUTIONS | 2,220 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,564 | -0,90 % | Lexaria Bioscience Corp.: Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule | KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that dosing began on schedule... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,790 | +4,70 % | Incannex Healthcare: Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea | MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,315 | +1,06 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LENSAR | 5,730 | +0,17 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 1,850 | -17,04 % | Jin Medical International Ltd. - 6-K, Report of foreign issuer | ||
| HEARTBEAM | 0,750 | +14,80 % | HeartBeam, Inc. - 8-K, Current Report |